CIPLA / NSE / Biotechnology & Drugs

Cipla

INR 1,401.318.00 (0.21%) 1D

Last updated: 2026-06-15T16:23:26.624052+00:00

Price Chart

1Y Price Trend

Open1,527

High1,673

Low1,165.7

Close1,389.4

Volume8,05,612

Change-137.6

Change %-9.01%

Key Information

Ticker SymbolCIPLA

Current Price1,401.3

52-Week High1,673

52-Week Low1,165.7

Market Cap1.13 L

Beta0.62

Volume8,05,612

ISININE059A01026

Day High1,396.1

Day Low1,382.2

Open1,393.9

Recommendations

RatingBuy

Target High1,672.2

Target Low1,165.55

Target Mean2.43

Target Median79.05

Risk Metrics

Overall RiskModerate risk

Board Risk23.49

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app

News

Latest stock news

Lilly Sues Cipla to Block Copy of Breast Cancer Drug Verzenio - Bloomberg Law News1 day ago

Market news

Lilly Sues Cipla to Block Copy of Breast Cancer Drug Verzenio Bloomberg Law News

Cipla's Goa facility gets VAI status after US FDA inspection - Moneycontrol.com5 days ago

Market news

Cipla's Goa facility gets VAI status after US FDA inspection Moneycontrol.com

Cipla Gets USFDA VAI Classification for Goa Manufacturing Facility - Medical Dialogues5 days ago

Market news

Cipla Gets USFDA VAI Classification for Goa Manufacturing Facility Medical Dialogues

Cipla's Goa plant gets VAI status from USFDA after April inspection; Here's what it means - CNBC TV186 days ago

Market news

Cipla's Goa plant gets VAI status from USFDA after April inspection; Here's what it means CNBC TV18

Reduce Cipla Ltd for the Target Rs. 1,350 by Choice Institutional Equities - Investment Guru6 days ago

Market news

Reduce Cipla Ltd for the Target Rs. 1,350 by Choice Institutional Equities Investment Guru

Cipla bets on innovation for 10% revenue share; expands US manufacturing to de-risk supply chains - Storyboard186 days ago

Market news

Cipla bets on innovation for 10% revenue share; expands US manufacturing to de-risk supply chains Storyboard18

Cipla wants new-age medicines to contribute 10% of revenue in five years - CNBC TV186 days ago

Market news

Cipla wants new-age medicines to contribute 10% of revenue in five years CNBC TV18

Yashu Arora Promoted to Group Business Head – Respiratory Orals Vertical at Cipla - hrtoday.in7 days ago

Market news

Yashu Arora Promoted to Group Business Head – Respiratory Orals Vertical at Cipla hrtoday.in